VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹31 Cr | ₹30 Cr | ₹40 Cr | ₹11 Cr | ₹0.16 Cr |
What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹0.16 Cr |
How is Contingent Liabilities of VENUS REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 0.51 | |
| Mar2024 | ₹30 Cr | -23.13 | |
| Mar2023 | ₹40 Cr | 272.42 | |
| Mar2022 | ₹11 Cr | 6,423.93 | |
| Mar2021 | ₹0.16 Cr | - | |
Compare Contingent Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,332.2 Cr | 7.7% | 31.6% | 201.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 7.7% |
31.6% |
201.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses